References
- Cavanagh JB. The significance of the "dying back" process in experimental and human neurological disease. Int Rev Exp Pathol 1964;3:219-67.
- Ehrich M, Jortner BS. Organophosphorus-induced delayed neuropathy. In: Krieger R, editor. Handbook of Pesticide Toxicology. Vol. 2. 2nd ed. San Diego (CA): Academic Press; 2001 . p. 987-1012.
- Johnson MK. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Rev Biochem Toxciol 1982;4:141-212.
- Lotti M. Organophosphorus compounds. In: Spencer PS, Schaumburg HH, Ludolph AC, editors. Experimental and Clinical Neurotoxicology. 2nd ed. New York (USA): Oxford University Press; 2000. p. 897-925.
- Lush MJ, Li Y, Read DJ, Willis AC, Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration associated mutant protein contain a novel domain conserved from bacteria to man. Biochem J 1998;332:1-4.
- Li Y, Dinsdale D, Glynn P. Protein domains, catalytic activity and subcellular distribution of neuropathy target esterase in mammalian cells. J Biol Chem 2003;278:8820-5.
- Zaccheo O, Dinsdale D, Meacock PA, Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Biol Chem 2004;279:24024-33.
- Mühlig-Versen M, Bettencourt da Cruz A, Tschäpe J-A, Moser M, Büttner R, Athenstaedt K, Glynn P, Kretzschmar D. Loss of Swiss cheese/Neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J Neurosci 2005;25:2865-73.
- Akassoglou K, Malester B, Xu J, Tessarollo L, Rosenbluth J, Chao M. Brain-specific deletion of neuropathy target esterase/swiss cheese results in neurodegeneration. Proc Natl Acad Sci (USA) 2004;101:5075-80.
- Veronesi B, Padilla S, Blackmon K, Pope C. Murine susceptibility to organophosphorus-induced delayed neuropathy. Toxciol Appl Pharmacol 1991;107:311-24.
- Lapadula DM, Patton SE, Campbell GA, Abou-Donia MB. Characterisation of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate Toxicol Appl Pharmacol 1985;79:83-90.
- Johnson MK, Lauwerys R. Protection by some carbamates against the delayed neurotoxic effects of di-isopropyl phosphorofluoridate. Nature 1969;222:1066-7.
- Johnson MK. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J Neurochem 1974;23:785-9.
- Johnson MK. Organophosphates and delayed neuropathy-is NTE alive and well? Toxicol Appl Pharmacol 1990;102:385-99.
- Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog Neurobiol 2000;61:61-74.
- Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol 1992;21:465-87.
- Moretto A, Lotti M, Sabri MI, Spencer PS. Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J Neurochem 1987;49:1515-22.
- Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. The swisscheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neuroscience 1997;17:7425-32.